Stock Market Today, Feb.: ImmunityBio Surges on Anktiva
Biotech headlines move markets. ImmunityBio, boosted by Anktiva's 700% revenue surge, sparked a rally that may signal...
Which Funds Have Best Annual Risk Adjusted Returns
Determine which funds deliver the best annual risk-adjusted returns and how they stack up. Compare contenders to pick winners.
28,456 articles
Spacemobile Buy, Sell, Hold: Near-Term Outlook for ASTS
AST SpaceMobile has surged, leaving investors asking whether spacemobile buy, sell, hold makes sense now. This articl...
Crypto Fight Questioning Things: SEC Eyes Novel ETFs
The SEC has launched a public-comment process on novel ETFs, signaling tighter rules for crypto assets and leverage a...
Home Sales Fall, Yet Trend Stays in Sideways Range
New-home sales slipped in April 2026, but the broader trend remains sideways. Builders linger in a cautious stance as...
She’s with Only $10,000 Saved: Retirement Reality Check
A 66-year-old faces retirement with scant savings. The plan: clear debt, maximize Social Security, and tighten spendi...
Still Flip Houses 2026? Real Investor Insights for Pros
Is flipping still viable in 2026? A seasoned investor who has done 60+ flips breaks down the truths, the loan options...
Why Shares Walmart Sinking Today: What Investors Should Do
When a blue-chip stock slips, it can be more noise than signal. This article dives into why shares walmart sinking to...
Will Verisk's Valuable Data Survive AI Commoditization?
As AI accelerates, the question for investors is clear: will Verisk's valuable data keep its edge or fade into a sea ...
Alex Murdaugh Walked Conviction and Your Finances Today
A courtroom twist showed how quickly legal drama can upend finances. This deep dive draws practical money lessons fro...
Tech Shakeup on the S&P 500: What It Means for Investors
A technology-driven rerating is reshaping the S&P 500. This article explains what a tech shakeup means for ordina...
Grail's Slump Enters Week: Navigating Biotech's Setback
Grail's stock has slid as its Galleri MCED test faced a major trial setback. This piece breaks down what happened, wh...
Is Viking Therapeutics Stock Going to $100? Key Signals
Viking Therapeutics sits at the intersection of biotech risk and big growth potential. This article breaks down what ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status